410 related articles for article (PubMed ID: 29468730)
1. Comparison of three treatment strategies for patients with triple-vessel coronary disease and left ventricular dysfunction.
Jiang L; Xu L; Song L; Gao Z; Tian J; Sun K; Yu H; Xu B; Song L; Yuan J
J Interv Cardiol; 2018 Jun; 31(3):310-318. PubMed ID: 29468730
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].
Liu R; Jiang L; Xu LJ; Tian J; Zhao XY; Zhang Y; Xu JJ; Song Y; Wang HH; Gao Z; Song L; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1049-1057. PubMed ID: 29325365
[No Abstract] [Full Text] [Related]
3. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
[TBL] [Abstract][Full Text] [Related]
4. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
Kang SH; Lee CW; Baek S; Lee PH; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
Am J Cardiol; 2017 Jul; 120(1):69-74. PubMed ID: 28483202
[TBL] [Abstract][Full Text] [Related]
6. Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China.
Zhao X; Xu L; Jiang L; Tian J; Zhang Y; Wang D; Sun K; Xu B; Zhao W; Hui R; Gao R; Song L; Yuan J
Cardiovasc Diabetol; 2021 Jan; 20(1):16. PubMed ID: 33430864
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Long-term Outcomes in Patients with Premature Triple-vessel Coronary Disease Undergoing Three Different Treatment Strategies: A Prospective Cohort Study.
Xu JJ; Zhang Y; Jiang L; Tian J; Song L; Gao Z; Feng XX; Zhao XY; Zhao YY; Wang D; Sun K; Xu LJ; Liu R; Gao RL; Xu B; Song L; Yuan JQ
Chin Med J (Engl); 2018 Jan; 131(1):1-9. PubMed ID: 29271373
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
[TBL] [Abstract][Full Text] [Related]
10. Coronary revascularization for patients with severe left ventricular dysfunction.
Nagendran J; Norris CM; Graham MM; Ross DB; Macarthur RG; Kieser TM; Maitland AM; Southern D; Meyer SR;
Ann Thorac Surg; 2013 Dec; 96(6):2038-44. PubMed ID: 23968761
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
[TBL] [Abstract][Full Text] [Related]
12. Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.
Nagendran J; Bozso SJ; Norris CM; McAlister FA; Appoo JJ; Moon MC; Freed DH; Nagendran J
J Am Coll Cardiol; 2018 Feb; 71(8):819-827. PubMed ID: 29471931
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
[TBL] [Abstract][Full Text] [Related]
14. Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction.
Park S; Ahn JM; Kim TO; Park H; Kang DY; Lee PH; Jeong YJ; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park SJ; Park DW;
J Am Coll Cardiol; 2020 Sep; 76(12):1395-1406. PubMed ID: 32943156
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.
Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L
Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Systolic Dysfunction.
Cui K; Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M
Am J Cardiol; 2018 Nov; 122(10):1670-1676. PubMed ID: 30220418
[TBL] [Abstract][Full Text] [Related]
17. Implications of left atrial volume index in patients with three-vessel coronary disease: A 6.6-year follow-up cohort study.
Liu R; Song L; Zhang C; Jiang L; Tian J; Xu L; Feng X; Wan L; Zhao X; Xu O; Li C; Gao R; Hui R; Zhao W; Yuan J
Chin Med J (Engl); 2024 Feb; 137(4):441-449. PubMed ID: 37262047
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
[TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
